Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.81026 | 81 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.78982 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.86651 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.704 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.50754 | 79 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.44765 | 87 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.8987 | 83 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.52768 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.00738 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.78738 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.33147 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.69521 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.79957 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.79189 | 81 |